找回密碼
 To register

QQ登錄

只需一步,快速開始

掃一掃,訪問微社區(qū)

打印 上一主題 下一主題

Titlebook: Electromanipulation in Hybridoma Technology; Carl A. K. Borrebaeck,Inger Hagen Book 1989 Palgrave Macmillan, a division of Macmillan Publi

[復(fù)制鏈接]
查看: 7410|回復(fù): 38
樓主
發(fā)表于 2025-3-21 19:58:03 | 只看該作者 |倒序瀏覽 |閱讀模式
書目名稱Electromanipulation in Hybridoma Technology
編輯Carl A. K. Borrebaeck,Inger Hagen
視頻videohttp://file.papertrans.cn/307/306065/306065.mp4
圖書封面Titlebook: Electromanipulation in Hybridoma Technology;  Carl A. K. Borrebaeck,Inger Hagen Book 1989 Palgrave Macmillan, a division of Macmillan Publi
描述A manual that details the techniques of electrofusion and electroporation by researchers who were the first to show that the platelet membrane glycoproteins GP IIb and GP IIIa are associated in a complex which triggered interest in electrofusion.
出版日期Book 1989
關(guān)鍵詞antibody; DNA; electroporation; glycoprotein; membrane; monoclonal antibodies; protein; proteins
版次1
doihttps://doi.org/10.1007/978-1-349-11339-2
isbn_ebook978-1-349-11339-2
copyrightPalgrave Macmillan, a division of Macmillan Publishers Limited 1989
The information of publication is updating

書目名稱Electromanipulation in Hybridoma Technology影響因子(影響力)




書目名稱Electromanipulation in Hybridoma Technology影響因子(影響力)學(xué)科排名




書目名稱Electromanipulation in Hybridoma Technology網(wǎng)絡(luò)公開度




書目名稱Electromanipulation in Hybridoma Technology網(wǎng)絡(luò)公開度學(xué)科排名




書目名稱Electromanipulation in Hybridoma Technology被引頻次




書目名稱Electromanipulation in Hybridoma Technology被引頻次學(xué)科排名




書目名稱Electromanipulation in Hybridoma Technology年度引用




書目名稱Electromanipulation in Hybridoma Technology年度引用學(xué)科排名




書目名稱Electromanipulation in Hybridoma Technology讀者反饋




書目名稱Electromanipulation in Hybridoma Technology讀者反饋學(xué)科排名




單選投票, 共有 1 人參與投票
 

1票 100.00%

Perfect with Aesthetics

 

0票 0.00%

Better Implies Difficulty

 

0票 0.00%

Good and Satisfactory

 

0票 0.00%

Adverse Performance

 

0票 0.00%

Disdainful Garbage

您所在的用戶組沒有投票權(quán)限
沙發(fā)
發(fā)表于 2025-3-21 20:31:58 | 只看該作者
Electroporation of Human Lymphoid Cells,n human B-cell immortalization.. The techniques most widely employed to immortalize human B cells include classical hybridoma technology using a tumor cell fusion partner and cell transformation/immortalization accomplished by infecting the target B cells with Epstein-Barr virus (EBV).. Both methodo
板凳
發(fā)表于 2025-3-22 04:15:35 | 只看該作者
地板
發(fā)表于 2025-3-22 06:48:22 | 只看該作者
Generating Immortalized Immunoglobulin-secreting Human Lymphocytes by Recombinant DNA Technology,ells), with an appropriate fusion partner, typically a myeloma or lymphoblastoid cell line, via the cumbersome and somewhat unpredictable polyethylene glycol (PEG) procedure.. The fusion partner simply acts as a vector, supplying immortalization functions to an immunoglobulin-secreting lymphocyte. R
5#
發(fā)表于 2025-3-22 11:02:34 | 只看該作者
B-Cell Hybridoma Production by Avidin-Biotin Mediated Electrofusion,ncements in the biomedical sciences and is widely used. The method is based on the random fusion of two cell types in the presence of polyethyleneglycol (PEG),. although viruses were used in earlier experiments.. Antibodies to a wide variety of antigens have been reported. Spleen cells from hyperimm
6#
發(fā)表于 2025-3-22 14:29:09 | 只看該作者
Hematological Disorders in Childrenved the way for the development of new tools in bioprocessing and genetic engineering.. Electroinjection (electropermeabilization or electroporation) of membrane-impermeable molecules of low and high molecular weight into living cells was the first application of this field pulse technique.. Researc
7#
發(fā)表于 2025-3-22 20:59:47 | 只看該作者
8#
發(fā)表于 2025-3-23 00:10:37 | 只看該作者
Aakanksha Singh,Mrinalini Kotru Although it is likely that human monoclonal antibodies (HMAbs) will have distinct advantages, particularly in therapeutic applications, the ability to produce HMAbs has lagged far behind those developed for the murine system. Three general problems have limited the development of HMAbs: the lack of
9#
發(fā)表于 2025-3-23 03:59:41 | 只看該作者
10#
發(fā)表于 2025-3-23 05:45:23 | 只看該作者
 關(guān)于派博傳思  派博傳思旗下網(wǎng)站  友情鏈接
派博傳思介紹 公司地理位置 論文服務(wù)流程 影響因子官網(wǎng) 吾愛論文網(wǎng) 大講堂 北京大學(xué) Oxford Uni. Harvard Uni.
發(fā)展歷史沿革 期刊點評 投稿經(jīng)驗總結(jié) SCIENCEGARD IMPACTFACTOR 派博系數(shù) 清華大學(xué) Yale Uni. Stanford Uni.
QQ|Archiver|手機版|小黑屋| 派博傳思國際 ( 京公網(wǎng)安備110108008328) GMT+8, 2025-10-14 06:33
Copyright © 2001-2015 派博傳思   京公網(wǎng)安備110108008328 版權(quán)所有 All rights reserved
快速回復(fù) 返回頂部 返回列表
卢氏县| 鲁山县| 肃宁县| 大石桥市| 五指山市| 龙陵县| 临安市| 杭锦后旗| 衢州市| 六盘水市| 吉木乃县| 丹东市| 聊城市| 来宾市| 清徐县| 葵青区| 潜江市| 娄烦县| 板桥市| 枞阳县| 敖汉旗| 孝昌县| 出国| 漳平市| 昌邑市| 郑州市| 攀枝花市| 兴仁县| 宝山区| 准格尔旗| 宁城县| 乐山市| 皋兰县| 龙海市| 沂水县| 太仆寺旗| 宜兰市| 中超| 彝良县| 永春县| 博罗县|